Saturday, July 11, 2026

Drug profile · INN

tiotropium + olodaterol

tiotropium + olodaterol (SPIOLTO RESPIMAT) is an FDA-listed pharmaceutical active ingredient. Associated with Boehringer Ingelheim Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — tiotropium + olodaterol

Quick answer

tiotropium + olodaterol (SPIOLTO RESPIMAT) is an FDA-listed pharmaceutical active ingredient. Associated with Boehringer Ingelheim Pty Ltd.

Key facts

INN tiotropium + olodaterol
Brand SPIOLTO RESPIMAT

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. tiotropium + olodaterol Phase 3 · Boehringer Ingelheim · Pulmonary Disease, Chronic Obstructive

Frequently asked questions

What is tiotropium + olodaterol?

tiotropium + olodaterol (SPIOLTO RESPIMAT) is an FDA-listed pharmaceutical active ingredient. Associated with Boehringer Ingelheim Pty Ltd.

What is the brand name for tiotropium + olodaterol?

SPIOLTO RESPIMAT is a marketed brand name for tiotropium + olodaterol. Check FDA Drugs@FDA for the current US label holder and prescribing information.